Home > PB Ratio > MEDICAMEN BIOTECH

MEDICAMEN BIOTECH
PB (Price/Book ) Ratio

The Current P/B Ratio of MEDICAMEN BIOTECH is 3.14.

Share Price ₹512.2Feb 07,2025
Market Cap ₹650.5 Cr
Book Value₹207.0 CrMar2024 - Consolidated Results
Price/Book 3.14xCalculated as MarketCap/Book Value
Explore Stock Analytics
COMMUNITY POLL
for MEDICAMEN BIOTECH
Please provide your vote to see the results
MEDICAMEN BIOTECH is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks

Definition & Calculation of PB (Price/Book ) ratio of MEDICAMEN BIOTECH

Price-to-Book ratio, P/B Multiple, or P/B Ratio is an important valuation multiple that is defined as:

P/B = Market Capitalization / Book Value

or, using per-share numbers:

P/B = Stock Price / Book Value Per Share

Applying the above formula, P/B ratio of MEDICAMEN BIOTECH is calculated as :

Current Market Cap [ ₹650.5 Cr] as on Feb 07,2025

(/) Book Value [ ₹207.0 Cr] based on Mar2024 - Consolidated Results

(=) P/B Ratio [ 3.14x ]

P/B Ratio indicates 'the multiple of book value' investors are willing to pay to own one share of the company.

Thus, for MEDICAMEN BIOTECH , the investors are currently willing to pay '3.14 times book value' to own 1 share of the company.

PB Multiples are one of the most widely used valuation multiple in industry.

Since P/B ratio uses Book Value in the calculation, P/B multiples are not always reliable for valuing companies with negative book value.

In such cases, you may consider using Price to Earnings ratio or Price to Sales ratio of MEDICAMEN BIOTECH !

The chart below summarizes the trend in P/B Ratio of MEDICAMEN BIOTECH over the last five years.

Historical PB (Price/Book ) ratio chart of MEDICAMEN BIOTECH


PB Ratio Performance Analysis for MEDICAMEN BIOTECH

- MEDICAMEN BIOTECH 's latest p/b ratio is 3.14x.

- MEDICAMEN BIOTECH 's p/b ratio for fiscal years ending Mar2024 to Mar2020 averaged 3.93x.

- MEDICAMEN BIOTECH 's operated at median p/b ratio of 4.51x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, MEDICAMEN BIOTECH 's p/b ratio peaked in Mar2022 at 5.67x.

- MEDICAMEN BIOTECH 's p/b ratio hit its five-year low in Mar2020 of 1.85x.


How does MEDICAMEN BIOTECH 's P/B Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Book ValuePB RatioMarket Cap
MEDICAMEN BIOTECH 206.993.14650.5
SUN PHARMACEUTICAL INDUSTRIES LTD63,666.806.59419,764.0
CIPLA LTD26,619.904.47118,905.0
DR REDDYS LABORATORIES LTD28,123.503.68103,523.0
ZYDUS LIFESCIENCES LTD19,829.505.04100,015.0
DIVIS LABORATORIES LTD13,571.0012.01163,010.0
MANKIND PHARMA LTD9,339.8411.12103,904.0
TORRENT PHARMACEUTICALS LTD6,856.1516.09110,313.0
LUPIN LTD14,175.807.08100,405.0
AUROBINDO PHARMA LTD29,842.802.3269,214.1
ABBOTT INDIA LTD3,658.7317.3163,315.3

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PB Analysis vs MEDICAMEN BIOTECH 's P/B Ratio

Top 10 Industry PeersPB Ratio
Min industry PB 2.32x
Max industry PB 17.31x
Median industry PB 6.59x
Average industry PB 8.08x



You may also like the below Video Courses